Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions

Analysis of gene-expression profiles led to the identification of three molecularly distinct subtypes of colon cancer. One of these subtypes is new, and its identification is of clinical interest because it tends to have a particularly unfavorable prognosis and is refractory to existing targeted therapies.